HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

miloxacin (AB206)

structure in second source

Also Known As:

AB206; AB 206; 5,8-dihydro-5-methoxy-8-oxo-1,3-dioxolo(4,5- g)quinoline-7-carboxylic acid

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        4-Quinolones: 66
        Oxolinic Acid: 89
        miloxacin: 3

Related Diseases

1.	Infections 09/01/1981 - "Therefore, the effectiveness of miloxacin against biliary tract infections and its excretion into bile in patients were investigated. " 09/01/1981 - "XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)]." 09/01/1981 - "These results show that miloxacin is expected to be fully applicable on the therapy of biliary tract infections." 07/01/1980 - "Miloxacin was less active against a Pseudomonas aeruginosa infection and inactive at the maximum test doses against a Streptococcus pyogenes infection." 07/01/1980 - "Miloxacin, a synthetic antibacterial agent structurally related to oxolinic acid, has a broad spectrum of activity in vitro against gram-negative bacteria and considerable activity in vivo against infections with these bacteria. "
2.	Pseudomonas Infections 07/01/1980 - "Miloxacin was less active against a Pseudomonas aeruginosa infection and inactive at the maximum test doses against a Streptococcus pyogenes infection."

Related Drugs and Biologics

1.	Oxolinic Acid
2.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Therapeutics